Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
An article from Medical Tourism Magazine included a study from The American Journal of Managed Care® (AJMC®) on medication nonadherence. The study, “Using Aggregated Pharmacy Claims to Identify Primary Nonadherence,” found that medication fill data within the provider electronic health record can identify primary nonadherence in clinical practice. According to the researchers, as adoption of the technology increases, it will offer an opportunity to intervene to improve adherence to therapy.
The National Pharmaceutical Council’s Monday CER Daily Newsfeed included an article from AJMC®’s sister site The Center for Biosimilars®. The article, “HTA Frameworks for RA Therapies Need Improvement, Researchers Say,” covered a paper that said current health technology assessments for rheumatoid arthritis rely on disease activity measures that are not aligned to guideline-recommended target measures of remission and that they might even be biased in favor of certain therapies insofar as they privilege measures like C-reactive protein reduction.
Regulatory Affairs Professionals Society’s Regulatory Focus mentioned The Center for Biosimilars®’ article “Abbvie and Boehringer Ingelheim Settle Over Biosimilar Adalimumab,” which covered AbbVie’s announcements that it had settled its patent litigation with Behringer Ingelheim (BI) over adalimumab. Under the terms of the settlement, BI’s biosimilar, Cyltezo, will not enter the market until July 1, 2023.
The Biologics Prescribers Collaborative’s Biologics & Biosimilars Update highlighted an article from The Center for Biosimilars® on the FDA’s approval of Samsung Bioepis’ etanercept biosimilar, SB4, as Eticovo. According to article, “FDA Approves Samsung Bioepis’ Etanercept Biosimilar, Eticovo,” the biosimilar was approved to treat all indications of its reference, Enbrel: rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Patient Navigation in Oncology at Heart of Priority Health White House Visit
April 24th 2024On March 27, Priority Health's president and CEO, Praveen Thadani participated in a discussion on how to expand and optimize patient navigation services in oncology care, as part of the Cancer Moonshot initiative.
Read More
Downward Morbidity, Mortality Trends Discovered Among Patients With Ovarian Cancer, Liver Metastases
April 24th 2024This study indicates a declining trend in morbidity and mortality rates among patients with ovarian cancer and liver metastases, highlighting the efficacy of surgery and chemotherapy in improving survival outcomes.
Read More